Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

EGX:AXPH Revenue

In the fiscal year ending June 30, 2025, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 2.75B EGP with 55.56% growth. Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 528.72M in the quarter ending June 30, 2025, with 101.81% growth.

• Revenue: 2.75B
• Revenue Growth: +55.56%
• P/S Ratio: 1.66
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	2.75B	982.44M	55.56%
Jun 30, 2024	1.77B	283.76M	19.12%
Jun 30, 2023	1.48B	384.31M	34.94%
Jun 30, 2022	1.10B	-4.24M	-0.38%
Jun 30, 2021	1.10B	79.44M	7.75%